Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,528 | 256 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $828.36 | 62 | $0 (2024) |
| ABBVIE INC. | $412.77 | 25 | $0 (2024) |
| ShockWave Medical, Inc | $316.71 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $314.06 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $308.74 | 11 | $0 (2024) |
| Abbott Laboratories | $301.05 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $223.99 | 14 | $0 (2023) |
| PFIZER INC. | $209.45 | 12 | $0 (2024) |
| Novo Nordisk Inc | $203.63 | 12 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $193.07 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,505 | 60 | ShockWave Medical, Inc ($316.71) |
| 2023 | $649.16 | 43 | ABBVIE INC. ($182.53) |
| 2022 | $705.07 | 43 | Lilly USA, LLC ($168.49) |
| 2021 | $410.91 | 28 | Lilly USA, LLC ($164.91) |
| 2020 | $90.40 | 6 | Allergan, Inc. ($19.34) |
| 2019 | $428.42 | 27 | Gilead Sciences, Inc. ($80.18) |
| 2018 | $343.68 | 23 | Amgen Inc. ($54.62) |
| 2017 | $394.85 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($91.75) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $148.38 | General |
| Category: Lithoplasty | ||||||
| 12/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: HIV | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes Care | ||||||
| 09/16/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: HIV | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: DIABETES | ||||||
| 08/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 952 | 1,651 | $253,983 | $67,631 |
| 2022 | 13 | 438 | 1,239 | $145,383 | $69,922 |
| 2021 | 25 | 794 | 1,767 | $151,585 | $76,536 |
| 2020 | 24 | 784 | 1,172 | $144,598 | $51,351 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 99 | $44,154 | $12,788 | 29.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $34,272 | $12,442 | 36.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 23 | 234 | $36,738 | $8,837 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 115 | $37,950 | $8,823 | 23.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 23 | 209 | $26,961 | $6,395 | 23.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 143 | $27,885 | $5,655 | 20.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 60 | $7,860 | $2,909 | 37.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 81 | 86 | $5,934 | $1,406 | 23.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 38 | $4,408 | $1,400 | 31.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 70 | 75 | $5,175 | $1,235 | 23.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 82 | 85 | $4,675 | $1,115 | 23.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 83 | 93 | $3,999 | $962.55 | 24.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 71 | 76 | $2,812 | $664.08 | 23.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 84 | $2,688 | $639.24 | 23.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $1,568 | $526.68 | 33.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 40 | $1,600 | $380.80 | 23.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 13 | 13 | $1,365 | $328.77 | 24.1% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 13 | 13 | $1,352 | $324.48 | 24.0% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 13 | 13 | $1,157 | $276.90 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 28 | $281.00 | $235.20 | 83.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $825.00 | $208.12 | 25.2% |
| 83735 | Magnesium level | Office | 2023 | 12 | 12 | $324.00 | $78.84 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 200 | $50,290 | $17,790 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 81 | $22,278 | $11,061 | 49.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 31 | 289 | $18,785 | $10,620 | 56.5% |
About Dr. Nathan Pekar, M.D
Dr. Nathan Pekar, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760479059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Pekar, M.D has received a total of $4,528 in payments from pharmaceutical and medical device companies, with $1,505 received in 2024. These payments were reported across 256 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,528).
As a Medicare-enrolled provider, Pekar has provided services to 2,968 Medicare beneficiaries, totaling 5,829 services with total Medicare billing of $265,439. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 10/01/2005
- Last Updated 01/11/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760479059
Products in Payments
- MOUNJARO (Drug) $371.93
- VRAYLAR (Drug) $337.65
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $316.71
- JARDIANCE (Drug) $305.24
- Qelbree (Drug) $193.07
- AIRSUPRA (Drug) $184.83
- TRELEGY ELLIPTA (Drug) $175.71
- EMGALITY (Drug) $159.13
- PROCLAIM (Device) $144.97
- TRULICITY (Drug) $123.46
- PREVNAR 20 (Biological) $113.71
- Ozempic (Drug) $111.71
- REXULTI (Drug) $95.95
- FARXIGA (Drug) $68.98
- ANORO (Drug) $60.19
- Dexcom G6 Transmitter (Medical Supply) $57.56
- AUVI-Q (Drug) $53.87
- Kerendia (Drug) $53.86
- Aimovig (Biological) $53.77
- Rybelsus (Drug) $52.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768